{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T09:27:11Z","timestamp":1783243631901,"version":"3.54.6"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.alit.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T17:59:40Z","timestamp":1557338380000},"page":"450-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased activity of lipoprotein-associated phospholipase A2 in non-severe asthma"],"prefix":"10.1016","volume":"68","author":[{"given":"Pawel","family":"Kuczia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Mastalerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Potaczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Cybulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislawa","family":"Bazan-Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-8739","authenticated-orcid":false,"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2019.04.004_bib1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.ATV.0000160551.21962.a7","article-title":"Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target","volume":"25","author":"Zalewski","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12 Suppl","key":"10.1016\/j.alit.2019.04.004_bib2","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.amjcard.2008.04.019","article-title":"Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2Testing into cardiovascular disease risk assessment guidelines","volume":"101","author":"Davidson","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.alit.2019.04.004_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1476-511X-10-170","article-title":"Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2(Lp-PLA2): a review","volume":"10","author":"Silva","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.alit.2019.04.004_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.CIR.0000156457.35971.C8","article-title":"Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen risk and cardiovascular health study","volume":"111","author":"Winkler","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.alit.2019.04.004_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cca.2016.12.006","article-title":"Lipoprotein-associated phospholipase A2 in coronary heart disease: review and meta-analysis","volume":"465","author":"Li","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.alit.2019.04.004_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.ATV.0000191655.87296.ab","article-title":"Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans","volume":"26","author":"Yang","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.alit.2019.04.004_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000153339.27064.14","article-title":"Endothelial function: cardiac events","volume":"111","author":"Lerman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.alit.2019.04.004_bib8","unstructured":"Global Initiative for Asthma. Global Initiative for Asthma - GINA 2016. Available from: http:\/\/ginasthma.org\/."},{"key":"10.1016\/j.alit.2019.04.004_bib9","first-page":"469","article-title":"Effects of obesity on asthma: immunometabolic links","volume":"128","author":"Miethe","year":"2018","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.alit.2019.04.004_bib10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.amjcard.2007.12.024","article-title":"Relation of adult-onset asthma to coronary heart disease and stroke","volume":"101","author":"Onufrak","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.alit.2019.04.004_bib11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/eci.12336","article-title":"Increased stroke risk among adult asthmatic patients","volume":"44","author":"Chung","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.alit.2019.04.004_bib12","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/ATVBAHA.115.305452","article-title":"Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis","volume":"35","author":"Tattersall","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.alit.2019.04.004_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ejim.2014.10.023","article-title":"Adult asthmatics increase the risk of acute coronary syndrome: a nationwide population-based cohort study","volume":"25","author":"Chung","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.alit.2019.04.004_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1183\/09031936.00150312","article-title":"Risk of deep vein thrombosis and pulmonary embolism in asthma","volume":"42","author":"Majoor","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2019.04.004_bib15","doi-asserted-by":"crossref","first-page":"1601014","DOI":"10.1183\/13993003.01014-2016","article-title":"Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case-control study from Sweden","volume":"49","author":"Z\u00f6ller","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2019.04.004_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1183\/09031936.00043313","article-title":"Asthma increases pulmonary thromboembolism risk: a nationwide population cohort study","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.alit.2019.04.004_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/cea.12734","article-title":"Asthma is associated with enhanced thrombin formation and impaired fibrinolysis","volume":"46","author":"Bazan-Socha","year":"2016","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2019.04.004_bib18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.jaci.2015.10.038","article-title":"Prothrombotic state in patients with severe and prednisolone-dependent asthma","volume":"137","author":"Sneeboer","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2019.04.004_bib19","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10753-017-0565-x","article-title":"Prothrombotic state in asthma is related to increased levels of inflammatory cytokines, IL-6 and TNF\u03b1, in peripheral blood","volume":"40","author":"Bazan-Socha","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.alit.2019.04.004_bib20","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1038\/s41598-017-11467-8","article-title":"Impaired fibrinolysis and lower levels of plasma \u03b12-macroglobulin are associated with an increased risk of severe asthma exacerbations","volume":"7","author":"Bazan-Socha","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2019.04.004_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.rmed.2018.06.023","article-title":"Increased blood levels of cellular fibronectin in asthma: relation to the asthma severity, inflammation, and prothrombotic blood alterations","volume":"141","author":"Bazan-Socha","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.alit.2019.04.004_bib22","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijcard.2013.11.029","article-title":"Links between allergy and cardiovascular or hemostatic system","volume":"170","author":"Potaczek","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.alit.2019.04.004_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.atherosclerosis.2016.05.045","article-title":"Serum IgE levels in coronary artery disease","volume":"251","author":"Kounis","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.alit.2019.04.004_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12931-017-0505-1","article-title":"The role of the endothelium in asthma and chronic obstructive pulmonary disease (COPD)","volume":"18","author":"Green","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.alit.2019.04.004_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/02770903.2017.1313272","article-title":"Investigation of the relationship between asthma and subclinical atherosclerosis by carotid\/femoral intima media and epicardial fat thickness measurement","volume":"55","author":"Y\u0131lmaz","year":"2018","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.alit.2019.04.004_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/ajrccm.156.1.9608084","article-title":"Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage","volume":"156","author":"Triggiani","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2019.04.004_bib27","first-page":"22","article-title":"Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma","volume":"6","author":"Tsukioka","year":"1996","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.alit.2019.04.004_bib28","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI5574","article-title":"Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma","volume":"103","author":"Stafforini","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.alit.2019.04.004_bib29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","article-title":"Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement","volume":"196","author":"Culver","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2019.04.004_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/jth.12798","article-title":"The balance of pro- and anticoagulant processes underlying thrombin generation","volume":"13","author":"Kremers","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.alit.2019.04.004_bib31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.20452\/pamw.4165","article-title":"Plasma fibrin clot structure and thromboembolism: clinical implications","volume":"127","author":"Z\u0105bczyk","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.alit.2019.04.004_bib32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1373\/clinchem.2006.066845","article-title":"High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients","volume":"52","author":"Corsetti","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.alit.2019.04.004_bib33","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2011-11-391532","article-title":"Asthma and coagulation","volume":"119","author":"De Boer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.alit.2019.04.004_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10753-007-9056-9","article-title":"Platelet activating factor as a mediator and therapeutic approach in bronchial asthma","volume":"31","author":"Kasperska-Zajac","year":"2008","journal-title":"Inflammation"},{"key":"10.1016\/j.alit.2019.04.004_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/ajrccm.162.2.9911084","article-title":"Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses","volume":"162","author":"Henig","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.alit.2019.04.004_bib36","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.164.6.3360","article-title":"Recombinant human platelet-activating factor- acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model","volume":"164","author":"Henderson","year":"2000","journal-title":"J\u00a0Immunol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893019300516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:08:57Z","timestamp":1761156537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893019300516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1323893019300516"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2019.04.004","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased activity of lipoprotein-associated phospholipase A2 in non-severe asthma","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}